科研之友
微信
新浪微博
Facebook
分享链接
摘要
Neuroendocrine tumors (NETs) are a complex group of malignancies with variable prognosis and response to treatment. For pancreatic neuroendocrine and carcinoid tumors, traditional cytotoxic chemotherapies have demonstrated minimal activity. Current approaches for treatment of metastatic disease use a combination of loco-regional and targeted biological therapies. Clinical trials remain critical for evaluation of new and promising therapeutic options for patients with NETs. Oncogene (2011) 30, 1497-1505; doi: 10.1038/onc.2010.548; published online 6 December 2010
- 出版日期2011-3
